Chief - Strategic Development, General Counsel, Corporate Secretary
Ms. Jane Wasman, J.D., is President International, General Counsel, Corporationrationrate Secretary of Acorda Therapeutics, Inc. She was appointed as President International of the Company on October 9, 2012. She served as Chief Strategic Development of the Company. From May 2004 until January 2012, she was the company Executive Vice President, General Counsel and Corporationrationrate Secretary. From 1995 to 2004, Ms. Wasman held various leadership positions at ScheringPlough Corporationrationration, including Staff Vice President and Associate General Counsel responsible for legal support for U.S. Pharmaceuticals operations, including sales, marketing and compliance; FDA regulatory matters; global research and development; and corporate licensing and business development. She served as Staff Vice President, International in 2001 and as Staff Vice President, European OperationsLegal from 1998 to 2000. Previously, Ms. Wasman specialized in litigation at Fried, Frank, Harris, Shriver & Jacobson. She also served as Associate General Counsel to the U.S. Senate Committee on Veteran?s Affairs. Ms. Wasman graduated Magna Cum Laude and Phi Beta Kappa from Princeton University and earned her J.D. from Harvard Law School
Wasman is a member of the board of directors and the executive committee of the board of the New York Biotechnology Association .
Management Efficency
The company has return on total asset (ROA) of 1.96 % which means that it generated profit of $1.96 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 47.8 % meaning that it created $47.8 on every $100 dollars invested by stockholders.
The company currently holds 1.14 M in liabilities. Acorda Therapeutics Inc has Current Ratio of 4.0 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Acorda Therapeutics, Inc., a commercialstage biopharmaceutical company, engages in the identification, development, and commercialization of therapies for multiple sclerosis , spinal cord injury , and other central nervous system disorders primarily in the United States. Acorda Therapeutics Inc [ACOR] is traded on NASDAQ in USA. It is located in Acorda Therapeutics, Inc.Ardsley, NY and employs 378 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
1.03%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
